Clinical policies and procedures
| Clinical policies and procedures |
Informed Consent for Transfusion - NZBS Policy (111P005) (pdf, 24 KB)
|
Consent for Use of Blood Products (111F131) (pdf, 58 KB)
|
NZBS Dispensing Policy (111P001) (pdf, 260 KB)
|
Dispensing of Interchangeable Blood Products (111D003) (pdf, 158 KB)
|
Directed Donations - NZBS Policy (111P066) (pdf, 32 KB)
|
Agreement to Provide Directed Blood Donation(s) (111F066a) (pdf, 18 KB)
|
Consent of Recipient/Parent/Guardian to Accept Directed Blood Donation(s) (111F066b) (pdf, 51 KB)
|
Distribution and Supply of Plasma Derived Fractionated Blood Products and Recombinant Products in New Zealand (160P002) (pdf, 491 KB)
|
List of Fractionated Products and Recombinant Products Approved for Distribution (111D132) (pdf, 200 KB)
|
NZBS Terms and Conditions relating to the Issue of Non-Conforming Products on Clinical Grounds (111P019) (pdf, 83 KB)
|
Exceptional Release of Non-Conforming Product (111M019) (pdf, 359 KB)
|
Request from Treating Clinician for Exceptional Release of Non-Conforming Product (111F019) (pdf, 105 KB)
|
Request for Blood Bank Tests and Blood Components or Products (111F018) (pdf, 199 KB)
|
Recording and Reporting the Supply of Unapproved Medicines under Section 29 of the Medicines Act (108M020) (pdf, 149 KB)
|
Medsafe Declaration/Notification Form for Medicines Supplied Pursuant to Section 29 of the Medicines Act 1981 (108E001) (pdf, 76 KB)
|
Unapproved Medicine Record (108F064) (pdf, 115 KB)
|
Acute Transfusion Reaction (ATR) - Notification to Blood Banks Form (111F009) (pdf, 615 KB)
|
Managing Notification of Adverse Reactions to Fractionated Blood Products (111M003) (pdf, 281 KB)
|
Fractionated Blood Product - Adverse Event Notification (111F003) (pdf, 211 KB)
|
Clinical Follow Up of Platelets Returning Initial Positive Results for Bacterial Contamination (111M012) (pdf, 176 KB)
|
Exceptional Release of Non-Conforming Platelet Component (111F024) (pdf, 237 KB)
|
CSL Product Complaint Process Flowchart (111D135) (pdf, 94 KB)
|
Blood Component Support of Rh(D) Negative Individuals (111P032) (pdf, 288 KB)
|
NZBS Policy on the Use of Fresh Blood (111P074) (pdf, 142 KB)
|
NZBS Policy on the Provision of CMV Antibody Negative Blood Components (111P067) (pdf, 115 KB)
|
Notification of a Special Blood Component Requirement (111F047) (pdf, )
|
Policy for Collection and Transfusion of Granulocytes (111P049) (pdf, 138 KB)
|
Policy for the Documentation of Procedural Information for Therapeutic Apheresis Procedures (111P056) (pdf, 32 KB)
|
NZBS Policy on Collection and Cryopreservation of Haematopoietic Progenitor Cell (HPC), Cord Blood (HPC, Cord Blood) for Directed HPC Transplantation (111P007) (pdf, 149 KB)
|
Haemovigilance Policy (111P010) (pdf, 209 KB)
|
Management of Clinical Requests for Non-Standard Blood Components (111P011) (pdf, 128 KB)
|
Request for a Non-Standard Component (111F054) (pdf, 126 KB)
|
You may need to download Adobe Reader to view the PDF files. It is available free from the Adobe site(external link).
Back to top
Subscribe
